Top Markets
Coin of the day
Eucrates Biomedical Acquisition Corp. Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.

EUCR
Clasificación en acciones #26004
Eucrates Biomedical Acquisition Corp. currently lacks substantial business... Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe. Established in 2020, this entity has its headquarters situated in New York, New York.
Precio por acción
$10.04
Última sincronización: 2023-05-05
Capitalización bursátil
$44.29M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Eucrates Biomedical Acquisition Corp. (EUCR)
Ganancias de Eucrates Biomedical Acquisition Corp. (EUCR)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Eucrates Biomedical Acquisition Corp., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Eucrates Biomedical Acquisition Corp. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras